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Birth Weight as a Risk Factor for Breast Cancer:
A Meta-Analysis of 18 Epidemiological Studies
Xiaohui Xu, Ph.D.,1 Amy B. Dailey, Ph.D.,1 Mary Peoples-Sheps, Dr.P.H.,1 Evelyn O. Talbott, Dr.P.H.,2
Ning Li, Ph.D.,1 and Jeffrey Roth, Ph.D.1
Abstract
Background: Birth weight has been identified as a birth-related factor associated with the risk of breast cancer.
However, the evidence is inconsistent.
Methods: To investigate the association between birth weight and breast cancer, we conducted a meta-analysis
of published studies between 1996 and 2008. Eighteen studies encompassing 16,424 breast cancer cases were
included in the meta-analysis. Data were combined using a fixed-effect or random-effect model depending on
the heterogeneity across studies.
Results: Women with their own birth weight >4000 g or 8.5 lb had a higher risk for developing breast cancer
than those with birth weight <2500 g or 3000 g (OR¼ 1.20, 95% CI 1.08, 1.34). Findings were also consistent with
a dose-response pattern effect. The summary effect estimate for breast cancer risk per 1 kg increase in birth
weight was statistically significant (random effects OR¼ 1.07, 95% CI 1.02, 1.12).
Conclusions: Although these results provided no evidence indicating whether birth weight is more strongly
related to early-onset than to later-onset breast cancer, our findings suggest an association between birth weight
and breast cancer. The underlying biological mechanism relating to this phenomenon needs additional study.
Introduction
Breast cancer is the most commonly diagnosed malig-nant neoplasm among females in the United States, ac-
counting for one of every three cancer diagnoses, with the
highest incidence among women >age 50.1 In 2007, over
40,000 women died of breast cancer in the United States. Al-
though the incidence of breast cancer has decreased slightly
in recent years, an estimated 178,480 new invasive cases of
breast cancer, including 62,030 new cases of in situ breast
cancer, were expected to occur annually among women.1,2
Epidemiological, clinical, and genetic studies have identified a
number of biological and social traits as risk factors of breast
cancer. These factors include familial history of breast cancer,
age, higher socioeconomic status, ionizing radiation, tallness
in adult life, alcohol consumption, susceptibility genes of
breast cancer 1 (BRCA1) and breast cancer 2 (BRCA2), and a
variety of hormonal and metabolic factors.3 However, these
well-established risk factors for female breast cancer do not
sufficiently elucidate the incidence pattern of this cancer, and
additional risk factors have to be considered to advance our
understanding of breast carcinogenesis and suggest future
intervention strategies.
Evidence has suggested that the prenatal period may be
particularly relevant for the development of future adult
breast cancer. Results from animal experiments and migrant
population studies support the potential influence of prenatal
life exposures on subsequent breast cancer development.4–7
Trichopoulos8 hypothesized that prenatal factors, such as
elevated hormone concentrations in utero, may increase sub-
sequent breast cancer risk. There are methodological and the-
oretical challenges that these studies face, however, including
the long induction period between exposure and disease as
well as lack of assurance about the critical time window of
exposure. Several epidemiological studies have since linked
birth weight as a marker of in utero environment with breast
cancer risk. Some studies have reported high birth weight as a
breast cancer risk factor,9–17 although other studies have not
supported this relationship.18–24
Despite the relatively large number of studies, the evidence
of an association between birth weight and breast cancer is
inconclusive. Thus, combining data across these studies is
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useful to determine the overall statistical pattern of evidence.
Three previous meta-analyses have been conducted to eval-
uate the association between birth weight and breast can-
cer.25–27 However, these studies inadequately addressed the
dose-responselike relationship between birth weight and
breast cancer (i.e., risk of breast cancer per 1 kg increase in
birth weight), and there are also concerns about heterogeneity
across studies that were not accounted for. A pooled analysis
of individual participant data was published in 2008,28 and
although the results of this study are important, the pooled
analysis method limited the number of studies that could he
used to conduct a trend analysis based on continuous data.
TheWorld Cancer Research Fund (WCRF) report, launched in
November 2007, examined breast cancer risk per 1 kg increase
in birth weight but included only six cohort studies.29 In ad-
dition, although the meta-analysis conducted by Michels
and Xue27 included analysis of potential effect modification
by menopausal status, there were a few questions about the
selection of studies, compatible birth weight category, and the
analytical methods related to this analysis.
This meta-analysis provides new information on the dose-
responselike relationship between birth weight and breast
cancer risk while also examining effect modification by
menopausal status in detail. The primary aims of this meta-
analysis were (1) to determine the overall risk for breast cancer
of the highest birth weight (4000 g or 8.5 lb) compared
with the lowest birth weight (<2500 g or 3000 g), (2) to assess
whether the association followed a dose-responselike pattern,
and (3) to determine if the association could be discerned
separately for women with breast cancer diagnosed at pre-
menopausal or postmenopausal status.
Materials and Methods
Study identification
We performed a systematic literature search of PUBMED,
EMBASE, and GOOGLE SCHOLAR Search Engine (scholar
.google.com) through 2008 to identify epidemiological studies
of the association between birth weight and breast cancer. We
used the index terms birth weight, breast cancer, risk factors,
and epidemiology in various combinations. A manual review
of references fromprimary or review articleswas performed to
identify any additional relevant studies. The studies included
in the meta-analysis were systematically selected based on the
following criteria: (1) studies were peer-reviewed and pub-
lished in English, (2) studies provided measures of odds ra-
tios (OR) or relative risk (RR) (e.g., unadjusted or adjusted
ORs) for breast cancer or the number of individuals (both cases
and controls or both cases and person-years) in different birth
weight strata as well as an indication of the uncertainty of the
central estimate (e.g., 95%confidence interval [CI]) correspond-
ing to birth weight strata, and (3) studies with more compre-
hensive covariate adjustment, focused on breast cancer, or
with compatible categorization of birthweightwere preferred.
From a review of abstracts identified in the database search,
32 articles were selected for a full review after excluding re-
view articles, studies of other risk factors, and commentary.
We further excluded 14 studies of the total of 32 studies. Two
studies did not provide adequate information for either di-
chotomous comparisons or trend analysis,21,30 2 twins studies
were excluded because we were concerned with differences
between twins and general birth populations, particularlywith
regard to birth weight,31,32 and 10 other studies were excluded
because their results were included in other detailed publica-
tions that provided more comprehensive results or adequate
information.10,16,17,19,20,22,33–36 Thus, the present meta-analysis
includes 18 unique studies: 11 case-control studies,9,13,18,23,37–43
and 7 cohort studies11,12,14,15,24,44,45 (Tables 1 and 2).
Data were extracted using standardized data extraction
forms. For each study, extracted information included study
country and year, study design, population characteristics
(country and age), source of birth weight information, num-
ber of cases, sample size, unadjusted or adjusted ORs, and
95%Cl in different birth weight strata. In addition, matching
factors for cases and controls and factors for which statistical
adjustment was performed were extracted.
Statistical analysis
Dichotomous comparisons. To obtain the association
between high birthweight (i.e.,4,000 g or8.5 lb) and risk of
breast cancer across studies, we used the lowest birth weight
stratum as the reference group, a standard that most of the
studies applied. A majority of the included studies used a
birth weight cutoff of <2500 g or <5.5 lb as the lowest birth
weight stratum. Only a few studies used a birth weight cutoff
of<3000 g as the lowest birth weight stratum.12,14,37,45 For the
statistical synthesis, the covariate adjusted ORs or RRs were
used if they were provided. If not, we used the raw data to
calculate the unadjusted OR or RR for the studies that used a
reference other than the lowest birth weight stratum or that
had no estimates for all age groups, if appropriate. To assess
the effects of birthweight on early-onset and later-onset breast
cancer, the dichotomous ORs or RRs were extracted sepa-
rately for premenopausal and postmenopausal women if the
data were available.
Trend analysis for unadjusted or adjusted strength of
association. To obtain a uniform measure of the trend, the
change in breast cancer risk per 1 kg increase in birth weight
was extracted from each study when the information was
provided. Otherwise, we used the method of corrected
for covariance of log RR described by Greenland and Long-
necker46 to quantify the change in risk per 1 kg increase in
birth weight for studies that provided information for three or
more birth weight strata. In this method, the regression co-
efficient and its Cls between the risk of breast cancer on the
logit scale and the median of birth weight in each category
were obtained. The ORs or RRs for the change in risk per 1 kg
increase in birth weight were estimated by exponentiation of
the regression coefficient.47,48
Meta-analysis: Estimations of summary effects and
heterogeneity evaluation. Each study contributed measures
of ORs or RRs of breast cancer comparing highest birthweight
to lowest birth weight for women of all ages, or separately by
menopausal status, or ORs or rate ratios per 1 kg increase in
birth weight (separately by menopausal status, if available).
As a summary estimate, we used the general variance-based
method, which provides an inverse variance weighted aver-
age of the study-specific estimates, to calculate the summary
effect estimate for either the dichotomous ORs or ORs per 1 kg
increase in birth weight. This summary effect estimate rep-
resents a weighted average estimate of the effect of birth
weight on breast cancer across the studies.
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For each fixed effects of ORs, we quantified the degree
of heterogeneity in the measures across studies with a
Q-statistic, which follows the chi-square distribution with de-
grees of freedom (df ) equal to the number of included studies
minus 1.49 In this study, if the p value of the Q-statistic was
<0.1, we considered studies to exhibit significant statistical
heterogeneity.50 In this case, a random-effects OR is reported.
The random-effects OR is also a weighted average of study-
specific ORs that considers heterogeneity and can be a rea-
sonable summary effect estimate of the effect of birth weight
on breast cancer when heterogeneity exists across studies. In
addition, we also calculated the I2-statistic, which is equal to
the Q-statistic minus the df and then divided by the Q-statistic
itself. Its CI was also calculated using the method described
by Higgins and Thompson.51 The I2-statistic is a quantita-
tive measure of the degree of between-study heterogeneity.
Smaller values of the I2-statistic suggested lower between-
study heterogeneity (0 in I2-statistic suggests no heterogene-
ity, and larger values indicate increasing heterogeneity).52
Publication bias. The funnel plot method was applied to
determine if there was publication bias among the included
studies.53 The funnel plot includes the log of the ORs as the
x-axis and the standard error (SE) of the log of ORs as the
y-axis. If the plot is asymmetrical, it is interpreted to imply
that publication bias is present. This method provides a direct
visual inspection.
Results
Description of studies
The 18 studies included in the meta-analysis were pub-
lished between 1996 and 2008. The study populations in-
cluded participants from the United States,9,11,39–41,43,44
Europe,12,15,23,24,37,38,42,45 and China,18 for a total of 16,424
women with breast cancer. The cases in these studies were
primarily obtained from cancer registries, hospital records, or
both. Birth weight was ascertained from birth records or in-
terviews and questionnaires (Table 1).
Birth weight and breast cancer
Fifteen studies provided estimates of the association be-
tween risk of breast cancer and birth weight using dichoto-
mous comparisons (highest vs. lowest). Among them,
8 studies presented the ORs or RRs for the effect of highest
birth weight on breast cancer among all women, regardless of
menopausal status. Figure 1 shows the forest plot for the
study-specific ORs or RRs of these studies and the summary
estimate across them. All 8 studies included in this meta-
analysis suggested a positive association between highest
birth weight and breast cancer risk, although the association
was statistically significant in only 2 of the studies (summary
fixed-effect OR 1.20, 95% CI 1.08, 1.34 for highest vs. lowest
birthweight). Therewas little heterogeneity in effect estimates
across the reviewed studies (Q-statistic¼ 4.52, p for hetero-
geneity¼ 0.72; I2-statistic¼ 0, 95% CI 0, 50%).
Figures 2 shows the forest plots of the association estima-
tes of highest birth weight on premenopausal and postmeno-
pausal breast cancer and the summary estimates across them.
Altogether, 9 studies provided adequate information to ascer-
tain the association between birth weight and premenopausal
breast cancer risk (Fig. 2A). Because of the heterogeneity
of the estimates (Q-statistic¼ 15.89, p for heterogeneity<0.05,
I2-statistic¼ 50%, 95% CI 0, 76.5%), a random-effects sum-
mary OR was calculated. The random-effects summary OR
FIG. 1. Odds ratio with corresponding 95% confidence intervals for breast cancer in women of all ages with highest (>4000 g
or 8.5 lb) vs. lowest (<2500 g or 3000 g) birth weight. The Q-statistic and I2-statistic tests indicated no heterogeneity (Q-
stastistic¼ 4.52, p for heterogeneity¼ 0.72, I2-statistic¼ 0, 95%CI 0, 50%). The fixed-effects odds ratio is 1.20 (95% CI 1.08, 1.34).
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was 1.37 (95%CI 0.98, 1.92) for the effect of highest birthweight
(4,000g or 8.5 lb) compared with the lowest birth weight
(<2500g, <5.5 lb, or <3000g). Only 6 studies provided ade-
quate information on postmenopausal breast cancer and birth
weight to allow the dichotomous comparison (Fig. 2B). The
heterogeneity in the association estimates from these 6 studies
was also significant (Q-statistic¼ 12.0, p for heterogeneity
<0.05, I2-statistic¼ 58%, 95%CI 0, 83%). The random-effects
OR was 1.13 (95%CI 0.85, 1.51).
Trend analysis
We conducted a separate meta-analysis to determine if
there is a log-linear effect of birth weight on breast cancer risk.
This analysis included 16 studies, which met the inclusion
criteria for the trend analysis, that is, the effect estimates of
breast cancer risk associated with a 1 kg increase in birth
weight being presented or estimated using the Greenland
and Longnecker method,46 and provided 19 effect estimates.
Figure 3 shows a forest plot of these study-specific effect es-
timates and the summary estimate across them. Among the
19 effect estimates, a positive association was found in 13
studies, although the association was statistically significant
in only 5 of the studies. A negative association was observed
in 6 other studies in addition to 1 with a statistically signifi-
cantly negative association (Fig. 3). There was an overall sta-
tistically significant association between breast cancer and
each 1 kg increase in birth weight (random-effects OR 1.07,
95% CI 1.02, 1.12). The effect estimates were heterogeneous
across studies (Q-statistic¼ 30.02, p for heterogeneity <0.05,
I2-statistic¼ 40%, 95% CI 0, 65%). The high heterogeneity
among the studies seemed to be a result of the effect among
African Americans in the study by Hodgson et al.41 The
overall heterogeneity became nonsignificant (Q-statistic¼
24.9, p for heterogeneity >0.10, I2-statistic¼ 30%, 95% CI 0,
62%) after excluding the study. However, the exclusion did
not substantially change the summary effect estimate (fixed-
effects OR¼ 1.08, 95% CI 1.02, 1.13)
Publication bias
Visual inspection of the funnel plots does not suggest
substantial publication bias suggested in this meta-analysis
(data not shown).
FIG. 2. (A) Odds ratio with corresponding 95% confidence intervals for premenopausal breast cancer risk with high (>4000 g
or 8.5 lb) vs. lowest (<2500 g or 3000 g) birth weight. The Q-statistic and I2-statistic tests indicated heterogeneity across stud-
ies (Q-statistic¼ 15.89, p for heterogeneity<0.05, I2-statistic¼ 50%, 95%CI 0, 76.5%). The random-effects odds ratio is 1.37 (95%
CI 0.98, 1.92). (B) Odds ratio with corresponding 95% confidence intervals for postmenopausal breast cancer risk with highest
vs. lowest birth weight. The Q-statistic and I2-statistic tests indicated heterogeneity across studies (Q-statistic¼ 12.0, p for
heterogeneity <0.05, I2-statistic¼ 58%, 95%CI 0, 83%). The random-effects odds ratios is 1.13 (95% CI 0.85, 1.51).
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Discussion
This meta-analysis of 18 epidemiological studies showed a
significant, albeit modest in magnitude, summary effect of
breast cancer risk with high birth weight (4000 g or 8.5 lb)
compared with the lowest category of birth weight (<2500 g
or 3000 g) among women of all ages. Our results (OR¼ 1.37,
95% CI 0.98, 1.92 for premenopausal women; OR¼ 1.13, 95%
CI 0.85, 1.51 for postmenopausal women) differed from the
estimates from the meta-analysis conducted by Michels and
Xue in 200627 (OR¼ 1.25, 95%CI 1.14, 1.38 for premenopausal
women; OR¼ 1.04, 95% CI 0.91, 1.19 for postmenopausal
women), with our estimates higher and approaching signifi-
cance for premenopausal women. The alternative analytic
strategy employed in the study and inclusion of additional
studies are the likely reasons behind these difference. In terms
of methodological differences, we employed a random-effects
model rather than a fixed-effects model to provide a summary
estimate accounting for the heterogeneity across the studies.
We also used more consistent and clear definitions of highest
(birth weight >4000 g)and referent (birth weight<2500 g or
<3000 g) categories in our analysis. In addition, we have an
alternative approach to Michels and Xue27 for combining ef-
fect estimates based on categorical birth weight together
with the effect estimates based on continuous birth weight to
generate a single summary estimate. In our analysis, we an-
alyzed both the categorical and continuous measurement, but
we did them separately. In addition to these methodological
differences, we included 3 publications from 200611,13,40 that
have become available since the publication of Michels and
Xue.27
The findings from this meta-analysis demonstrated a
clear dose-response relation between birth weight and breast
cancer risk after accounting for the heterogeneity across the
studies. These results indicated that breast cancer risk in-
creased approximately 7% per 1 kg increase in birth weight.
Our results were consistent with the findings of the WCRF
report,29 which indicated that breast cancer risk increased 8%
per 1 kg increase in birth weight (based on 6 cohort studies).
Another pool analysis14 indicated that breast cancer risk in-
creased 6% per l SD (0.5 kg) increase in birth weight; our es-
timate is slightly lower but comparable. Our study adds
FIG. 3. Study-specific effect estimates for breast cancer risk per 1 kg increase in birth weight. The Q-statistic and I2-statistic
tests indicated the presence of heterogeneity across studies (Q-statistic¼ 30.02, p for heterogeneity <0.05, I2-statistic¼ 40%,
95% CI 0, 65%). The random-effects OR was 1.07 (95% CI 1.02, 1.12) apre, premenopausal women; post, postmenopausal
women. bHodgson’s 2004 study provided effect estimates for white and African American women, respectively.
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additional information that pooled analyses might be unable
to quantify. We were able to include additional studies that
measured birth weight only in categorical variables by using
the Greenland and Longneckermethod46 to estimate the dose-
response relationship. In our meta-analysis, although the ef-
fect estimate among premenopausal women is larger in
magnitude than the effect among postmenopausal women,
the association was not statistically significant. Even with the
inclusion of additional studies that provided adequate infor-
mation for stratification by menopausal status and applying
the Greenland and Longnecker methods for estimating dose-
response relationships incorporating categorical measures,
our findings remain consistent with the earlier meta-analyses.
Birth weight as a proxy indicator of intrauterine environ-
ment has been linked with several hormone-related cancers,
including testicular cancer,54–56prostatecancer,57–59andbreast
cancer, and other types of cancers, such as childhood leuke-
mia.60–62 Although the underlying biological mechanisms
that link high birth weight to a higher risk of breast cancer are
still ambiguous, the findings from recent animal studies and
epidemiological studies might provide clues to elucidate the
association. We know that estrogen plays a major role in the
etiology of breast cancer.63,64 Hence, hormonal exposures in
early life might have a particularly significant influence on the
subsequent breast cancer risk in adult life because the fetus is
particularly susceptible to transient hormonal exposure and
the change in the hormonal environment of the fetus alters the
development of target organs by exerting lifelong effects.65,66
In animal experiments, exposure to estrogens during fetal or
early postnatal development can increase mammary tumori-
genesis by changing both proliferation and differentiation of
the mammary gland.67 Several epidemiological studies found
that dizygotic twins who were exposed to more estrogens
in utero because of two placentas have a higher risk of breast
cancer than singleton births.68–70 Pregnancy estrogen lev-
els have been reported positively associated with birth
weight.71–73 Therefore, high birth weight, like twinning,
might be a proxy variable of early life exposure to high levels
of pregnancy estrogens, as Trichopoulos proposed.8
Another potential mechanism is that women with high
birth weight may merely have a higher number of mammary
gland cells at risk for transformation and, thus, have an in-
creased subsequent breast cancer risk.74 Findings from the
study by Cerhan et al.75 that birth weight was positively as-
sociated with mammographic breast density and dense area
among women support the hypothesis because mammo-
graphic density is strongly correlated with mammary gland
mass, which is also potentially associated with the mammary
cells at risk for transformation.74 However, the specific bio-
logical mechanisms remain poorly understood. An important
next step is to investigate more thoroughly plausible biolog-
ical pathways that may explain the relationship between birth
weight and breast cancer risk.
Some potential limitations of the meta-analysis should be
considered. Publication bias is always a serious concern for
meta-analyses; however, visual inspection of the funnel plots
did not provide any obvious evidence of publication bias
across studies. Many included studies also investigated ad-
ditional intrauterine environmental factors associated with
breast cancer, which could increase the chance of inclusion
of studies with a nonsignificant association between birth
weight and breast cancer and, consequently, reduce the po-
tential publication bias. Bias within studies, such as infor-
mation bias or selection bias, could also have influenced the
validity of this meta-analysis study. In 7 of the studies we
included, birth weight information was obtained from inter-
views or questionnaires. Recall bias might be amajor problem
among these studies. However, 1 study indicated that the
birth information directly reported from the mother is as
precise as the information from medical records.76 Therefore,
the influence of recall bias in these studies could be negligible.
Misclassification of cases might stem from the method of
ascertaining the outcome through cancer registries as the re-
sult of possible incomplete reporting,77–79 errors in the reg-
istry,80–82 mismatched cases,83 residential mobility, and
subsequent losses to follow-up. Although the potential impact
of this problem is difficult to evaluate, there is no reason to
believe that the misclassification is differential with regard to
the breast cancer outcome among different birth weight ca-
tegories. Finally, the inconsistent findings across the included
studies might result from the differences in sample sizes,
study populations, measurement cutoff points of birth
weight, or other study design characteristics, such as inclusion
of different potential confounding variables.
Overall, the results of this study supported the hypothesis
that birth weight plays an important role in determining
breast cancer risk in adult life. In particular, our findings in-
dicated that breast cancer risk increased approximately 7%
per 1 kg increase in birth weight. These results underscore the
importance of conducting additional studies to clarify the
underlying biological mechanisms that may further our un-
derstanding of the relationship between birth weight and
breast cancer. This meta-analysis did not reveal effect modi-
fication by menopausal status, and additional studies are
warranted because of the limited number of studies that
stratified by this factor. In addition, more studies with im-
proved research methods and analytic approaches are war-
ranted to address the question ofwhether birthweight ismore
strongly associated with early-onset than with later-onset
breast cancer.
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